학술논문
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
Document Type
Article
Author
Source
In Annals of Oncology February 2017 28(2):354-361
Subject
Language
ISSN
0923-7534